JMPWA
FLNA

JP Morgan Private Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,700
Closed -$28K – 1612
2018
Q2 		$28K Hold
13,700
– – ﹤0.01% 1450
2018
Q1 		$97K Buy
+13,700
New +$92.5K ﹤0.01% 1226

Other funds holding FLNA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

JP Morgan Private Wealth Advisors's FLNA Position: Q3 2018 in Review

JP Morgan Private Wealth Advisors sold out of Filana Therapeutics (FLNA) in Q3 2018, closing a stake of 13,700 shares — an estimated $28K sold.

JP Morgan Private Wealth Advisors first reported a position in FLNA in Q1 2018 and held it in 2 quarters. The position peaked at $97K in Q1 2018. 25 funds tracked by Wall St. Rank hold FLNA as of Q3 2018.

  • JP Morgan Private Wealth Advisors reported no remaining Filana Therapeutics position as of Q3 2018 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 13,700 Filana Therapeutics shares in Q3 2018, an estimated $28K.
  • JP Morgan Private Wealth Advisors first reported a position in Filana Therapeutics in Q1 2018 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Filana Therapeutics position peaked at $97K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.